InBodyLtd Future Growth

Future criteria checks 2/6

InBodyLtd is forecast to grow earnings and revenue by 13.9% and 13.2% per annum respectively. EPS is expected to grow by 11.1% per annum. Return on equity is forecast to be 15.6% in 3 years.

Key information

13.9%

Earnings growth rate

11.1%

EPS growth rate

Medical Equipment earnings growth	40.9%
Revenue growth rate	13.2%
Future return on equity	15.6%
Analyst coverage	Low
Last updated	23 Feb 2024

Recent future growth updates

Recent updates

InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital

Apr 12

Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)

Mar 25

Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Mar 08

Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?

Feb 18

How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 31

Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?

Jan 11

InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24

Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)

Dec 17

InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 02

Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?

Nov 17

Earnings and Revenue Growth Forecasts

KOSDAQ:A041830 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	222,100	48,450	43,500	47,500	2
12/31/2024	197,200	41,350	35,500	39,000	2
12/31/2023	170,351	36,723	31,058	38,686	N/A
9/30/2023	171,523	35,376	31,552	37,222	N/A
6/30/2023	165,663	32,528	35,212	41,247	N/A
3/31/2023	164,431	34,112	29,908	35,998	N/A
12/31/2022	160,004	33,816	24,402	30,419	N/A
9/30/2022	154,925	36,465	12,603	26,992	N/A
6/30/2022	149,075	34,329	11,047	24,743	N/A
3/31/2022	143,399	34,038	15,509	27,809	N/A
12/31/2021	137,837	34,033	18,368	30,351	N/A
9/30/2021	128,762	31,729	33,120	34,657	N/A
6/30/2021	125,036	30,556	34,879	36,687	N/A
3/31/2021	112,334	22,620	28,008	29,932	N/A
12/31/2020	107,122	17,518	26,581	28,500	N/A
9/30/2020	109,493	14,492	18,023	20,897	N/A
6/30/2020	107,806	13,559	15,980	18,609	N/A
3/31/2020	116,393	19,969	20,210	22,925	N/A
12/31/2019	117,059	20,428	20,974	24,206	N/A
9/30/2019	113,404	21,164	23,353	26,767	N/A
6/30/2019	110,791	22,187	19,624	25,403	N/A
3/31/2019	106,381	21,398	-16,094	25,190	N/A
12/31/2018	99,635	19,671	-23,234	17,705	N/A
9/30/2018	98,925	21,918	-25,462	14,546	N/A
6/30/2018	98,352	21,686	-24,373	13,837	N/A
3/31/2018	95,337	20,570	8,577	13,077	N/A
12/31/2017	93,254	19,322	12,995	18,576	N/A
9/30/2017	86,462	17,506	N/A	20,600	N/A
6/30/2017	80,006	14,859	N/A	16,750	N/A
3/31/2017	76,806	14,574	N/A	19,353	N/A
12/31/2016	79,848	16,987	N/A	18,238	N/A
9/30/2016	79,954	16,853	N/A	14,624	N/A
6/30/2016	80,356	19,165	N/A	16,789	N/A
3/31/2016	76,561	18,359	N/A	14,651	N/A
12/31/2015	68,949	17,311	N/A	11,179	N/A
9/30/2015	61,594	13,802	N/A	11,679	N/A
6/30/2015	54,675	10,615	N/A	10,386	N/A
3/31/2015	52,053	9,302	N/A	8,039	N/A
12/31/2014	48,940	8,879	N/A	10,259	N/A
9/30/2014	45,498	9,160	N/A	9,515	N/A
6/30/2014	42,966	8,362	N/A	9,828	N/A
3/31/2014	39,831	7,060	N/A	7,904	N/A
12/31/2013	36,787	6,194	N/A	6,995	N/A
9/30/2013	35,676	5,545	N/A	7,613	N/A
6/30/2013	34,602	5,357	N/A	5,319	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A041830's forecast earnings growth (13.9% per year) is above the savings rate (2.5%).

Earnings vs Market: A041830's earnings (13.9% per year) are forecast to grow slower than the KR market (28.4% per year).

High Growth Earnings: A041830's earnings are forecast to grow, but not significantly.

Revenue vs Market: A041830's revenue (13.2% per year) is forecast to grow faster than the KR market (9.1% per year).

High Growth Revenue: A041830's revenue (13.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A041830's Return on Equity is forecast to be low in 3 years time (15.6%).

InBodyLtd Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Price target increased to ₩34,000

Recent updates

Full year 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of ₩300 per share at 1.2% yield

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 18%

Upcoming dividend of ₩200 per share

No independent directors

InBody Releases BPBIO 220 and BPBIO 250

No independent directors

Inbody Co.,Ltd Releases New Bwa 2.0 Body Water Analyzer

Upcoming dividend of ₩140 per share

Price target increased to ₩34,000

Investor sentiment improved over the past week

InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital

Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)

Full year 2020 earnings released: EPS ₩1,335 (vs ₩1,532 in FY 2019)

Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?

New 90-day high: ₩19,600

How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: ₩19,200

Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?

New 90-day high: ₩18,500

InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Upcoming Dividend of ₩140 Per Share

Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)

New 90-day high: ₩18,300

InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?

New 90-day high: ₩17,450

New 90-day low: ₩15,300

New 90-day low - ₩15,350

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies